Cancer Genetics Acquires Gentris for $6,250,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ee28d752-4656-459b-b8e0-03c23fe1970c
Date
6/24/2014
Company Name
Gentris
Mailing Address
133 Southcenter Court Morrisville, NC 27560 USA
Company Description
Gentris Corporation is a leading global provider of applied clinical pharmacogenomic services and diagnostic product solutions.
Website
http://www.gentris.com
Transaction Type
M&A
Transaction Amount
$6,250,000
Transaction Round
Proceeds Purposes
M&A Terms
The purchase price is $3.25 million in cash, $1.5 million in Cancer Genetics stock, and performance-based earn outs up to $1.5 million, according to a news release.